Literature DB >> 1535492

Immunotherapy of rheumatoid arthritis.

R A Watts1, J D Isaacs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1535492      PMCID： PMC1005683          DOI： 10.1136/ard.51.5.577

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  26 in total

1.  Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis.

Authors:  D Wendling; J Wijdenes; E Racadot; B Morel-Fourrier
Journal:  J Rheumatol       Date:  1991-03       Impact factor: 4.666

Review 2.  The potential role of B-lymphocytes in the pathogenesis of rheumatoid arthritis.

Authors:  E M Andrew; C Plater-Zyberk; C M Brown; D G Williams; R N Maini
Journal:  Br J Rheumatol       Date:  1991

Review 3.  Monoclonal antibody treatment of rheumatoid arthritis.

Authors:  G Kingsley
Journal:  Br J Rheumatol       Date:  1991

4.  Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage.

Authors:  H E Paulus; H I Machleder; S Levine; D T Yu; N S MacDonald
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

5.  Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone.

Authors:  M Q Xia; M Tone; L Packman; G Hale; H Waldmann
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

Review 6.  Immunosuppressive drug therapy for rheumatic disease.

Authors:  W J McCune; G E Bayliss
Journal:  Curr Opin Rheumatol       Date:  1991-06       Impact factor: 5.006

7.  Lymphocytapheresis--a feasible treatment for rheumatoid arthritis.

Authors:  P Emery; G N Smith; G S Panayi
Journal:  Br J Rheumatol       Date:  1986-02

8.  Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.

Authors:  D Goldberg; P Morel; L Chatenoud; C Boitard; C J Menkes; P H Bertoye; J P Revillard; J F Bach
Journal:  J Autoimmun       Date:  1991-08       Impact factor: 7.094

9.  The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.

Authors:  S P Cobbold; G Martin; H Waldmann
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

10.  Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.

Authors:  G E Ranges; S Sriram; S M Cooper
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307
View more
  4 in total

Review 1.  Management of rheumatic diseases in children.

Authors:  B H Athreya
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells.

Authors:  Khalequz Zaman; Marie H Hanigan; Alison Smith; John Vaughan; Timothy Macdonald; David R Jones; John F Hunt; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

3.  Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H.

Authors:  S Brett; G Baxter; H Cooper; J M Johnston; J Tite; N Rapson
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages.

Authors:  B Joe; B R Lokesh
Journal:  Lipids       Date:  1997-11       Impact factor: 1.880
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.